BRKB

503.35

-0.19%↓

BRKA.US

754,827.3

-0.17%↓

JPM

312.96

-0.64%↓

V

345.54

+0.3%↑

MA

565.97

+0.25%↑

BRKB

503.35

-0.19%↓

BRKA.US

754,827.3

-0.17%↓

JPM

312.96

-0.64%↓

V

345.54

+0.3%↑

MA

565.97

+0.25%↑

BRKB

503.35

-0.19%↓

BRKA.US

754,827.3

-0.17%↓

JPM

312.96

-0.64%↓

V

345.54

+0.3%↑

MA

565.97

+0.25%↑

BRKB

503.35

-0.19%↓

BRKA.US

754,827.3

-0.17%↓

JPM

312.96

-0.64%↓

V

345.54

+0.3%↑

MA

565.97

+0.25%↑

BRKB

503.35

-0.19%↓

BRKA.US

754,827.3

-0.17%↓

JPM

312.96

-0.64%↓

V

345.54

+0.3%↑

MA

565.97

+0.25%↑

Search

Aflac Inc

Uždarymo kaina

SektoriusFinansų sektorius

110.41 -0.05

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

109.41

Max

110.74

Pagrindiniai rodikliai

By Trading Economics

Pajamos

1B

1.6B

Pardavimai

575M

4.8B

P/E

Sektoriaus vid.

14.633

29.428

Pelnas, tenkantis vienai akcijai

2.49

Dividendų pajamingumas

2.04

Pelno marža

34.196

Darbuotojai

12,694

EBITDA

1.9B

2.7B

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+2.66% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

2.04%

3.82%

Kitas uždarbis

2026-02-04

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

2.4B

60B

Ankstesnė atidarymo kaina

110.46

Ankstesnė uždarymo kaina

110.41

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

Aflac Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-18 23:54; UTC

Karštos akcijos

Stocks to Watch: Nike, Cassava Sciences, KB Home

2025-12-18 23:51; UTC

Uždarbis

Nike Sales Tick Up in 2Q; China Weakness Persists -- Update

2025-12-18 23:39; UTC

Pagrindinės rinkos jėgos

Cassava Sciences Shares Fall After FDA Places Hold on Epilepsy Drug Trial

2025-12-18 22:57; UTC

Įsigijimai, susijungimai, perėmimai

TikTok Signs Agreement for Sale of U.S. Unit, Axios Reports, Citing a Memo

2025-12-18 21:40; UTC

Uždarbis

Nike Sales Tick Up, But China Weakness Persists

2025-12-18 23:45; UTC

Rinkos pokalbiai

Gold Steady, Supported by Fed Rate-Cut Prospects -- Market Talk

2025-12-18 23:37; UTC

Rinkos pokalbiai
Uždarbis

Nike 2Q Results Fail to Convince Investors of Recovery -- Market Talk

2025-12-18 23:36; UTC

Rinkos pokalbiai

Nikkei May Rise, Tracking Wall Street's Rally -- Market Talk

2025-12-18 23:03; UTC

Įsigijimai, susijungimai, perėmimai

Mitsubishi Materials: Impact on Consolidated Results for FY Ending March 2026 Likely to be Immaterial

2025-12-18 23:02; UTC

Įsigijimai, susijungimai, perėmimai

Mitsubishi Materials: To Acquire 4,448 Common Shares, 13,771 Preferred Shares of Co.

2025-12-18 23:00; UTC

Įsigijimai, susijungimai, perėmimai

Mitsubishi Materials: Investment to Strengthen Recovery Network in U.S.

2025-12-18 22:59; UTC

Įsigijimai, susijungimai, perėmimai

Mitsubishi Materials: Investment to Contribute to Expanding Collection Volume of Secondary Raw Material

2025-12-18 22:58; UTC

Įsigijimai, susijungimai, perėmimai

SpaceX Could Go Public by Merging With EchoStar. It Isn't a Crazy Idea. -- Barrons.com

2025-12-18 22:57; UTC

Įsigijimai, susijungimai, perėmimai

Mitsubishi Materials: Elemental USA E-Waste Operates E-Waste Recycling Business in U.S.

2025-12-18 22:56; UTC

Įsigijimai, susijungimai, perėmimai

Mitsubishi Materials: To Acquire Portion of Shares of Elemental USA E-Waste & ITAD

2025-12-18 22:55; UTC

Uždarbis

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

2025-12-18 21:59; UTC

Uždarbis

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

2025-12-18 21:50; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-12-18 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-18 21:35; UTC

Uždarbis

FedEx's Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

2025-12-18 21:31; UTC

Uždarbis

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

2025-12-18 21:15; UTC

Uždarbis

Nike 2Q Europe, Middle East & Africa Rev $3.39B >NKE

2025-12-18 21:15; UTC

Uždarbis

Nike 2Q Greater China Rev Down 17% >NKE

2025-12-18 21:15; UTC

Uždarbis

Nike 2Q EPS 53c >NKE

2025-12-18 21:15; UTC

Uždarbis

Nike 2Q Apparel Rev $3.91B >NKE

2025-12-18 21:15; UTC

Uždarbis

Nike 2Q Equipment Rev $550M >NKE

2025-12-18 21:15; UTC

Uždarbis

Nike 2Q N Amer Rev $5.63B >NKE

2025-12-18 21:15; UTC

Uždarbis

Nike 2Q Footwear Rev $7.66B >NKE

2025-12-18 21:15; UTC

Uždarbis

Nike 2Q Asia Pacific & Latin America Rev Down 4% >NKE

2025-12-18 21:15; UTC

Uždarbis

Nike 2Q Greater China Rev $1.42B >NKE

Akcijų palyginimas

Kainos pokytis

Aflac Inc Prognozė

Kainos tikslas

By TipRanks

2.66% į viršų

12 mėnesių prognozė

Vidutinis 112.4 USD  2.66%

Aukščiausias 127 USD

Žemiausias 101 USD

Remiantis 10 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Aflac Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

10 ratings

2

Pirkti

5

Laikyti

3

Parduoti

Techninis įvertinimas

By Trading Central

105.92 / 109.14Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Aflac Inc

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
help-icon Live chat